par Esme Fowler-Mason | Mai 7, 2026 | Access to Care, NCD Solutions, Actualités, Uncategorized
The devices are available. The prices are negotiated. So why aren’t patients benefiting? Across low- and middle-income countries (LMICs), significant progress has been made in expanding access to noncommunicable disease (NCDs) diagnostics. Devices have been sourced....
par Esme Fowler-Mason | Avr 9, 2026 | Access to Care, NCD Partnerships, Actualités
As a member of the UICC-led ATOM Coalition, NCDconnect has partnered with Bristol Myers Squibb (BMS) and Coalition partners to help implement BMS’ Innovative Medicines Access Program (IMAP). NCDconnect plays a critical role in this by designing country-specific...
par Esme Fowler-Mason | Nov 27, 2025 | Healthcare Systems, NCD Solutions, Actualités
Noncommunicable diseases (NCDs) are on the rise across low- and middle-income countries (LMICs), adding pressure to already complex health supply chains. Ensuring consistent, affordable access to essential NCD medicines remains a critical, and often under-addressed,...
par Esme Fowler-Mason | Oct 23, 2025 | Access to Care, NCD Solutions, Actualités
Rituximab, a life-saving monoclonal antibody used in the treatment of blood cancers, is now available as a biosimilar through NCDconnect, ensuring quality, affordability, and access to targeted cancer therapies across low- and middle-income countries (LMICs). Pharmacy...
par Esme Fowler-Mason | Oct 7, 2025 | Behind the Scenes
For our Meet the Team series, we spoke with Suby Sanju, Strategic Sourcing Manager at IDA Foundation in Mumbai. Suby plays a key role in sourcing medicines for the NCDconnect platform, ensuring that quality, affordable treatments for noncommunicable diseases (NCDs)...
